Ekaterina Kirsanova, Olga Cherkashina, Elena Smirnova
{"title":"Whorled Endoplasmic Reticulum: For Better or for Worse?","authors":"Ekaterina Kirsanova, Olga Cherkashina, Elena Smirnova","doi":"10.1002/cbin.70230","DOIUrl":"10.1002/cbin.70230","url":null,"abstract":"<div>\u0000 \u0000 <p>The primary function of the endoplasmic reticulum (ER) is co-translational translocation, modification, and folding of secretory, lysosomal, and transmembrane proteins. The ER is a highly dynamic organelle undergoing rapid structural and functional changes in response to intra- and extracellular signals. Accumulation within the ER of unfolded or misfolded proteins, termed ER stress, poses a lethal threat to cells. In response, cells activate a signaling cascade, called an unfolded protein response (UPR). UPR restores ER homeostasis by enhancing the organelle's folding capacity and reducing its protein load. ER stress in various cell types has often been associated with the formation of specific ER configuration, termed whorls. However, these structures appear under physiological conditions (or in models mimicking such states) and/or may be induced by natural stimuli such as high biosynthetic demand, physiological ER stress, or synthesis of cytotoxic compounds. Whorls can be stimulated in cells where they have not been previously documented, upon exposure to chemical ER stress/UPR inducers or following overexpression/mutation of ER membrane proteins. Under such conditions, cells may generate whorls to sequester and subsequently degrade aberrant, toxic, or overproduced proteins and membranes. Cells appear to utilize whorls to modulate metabolic activity, store proteins and membranes, and isolate or degrade damaged, toxic, or excessed substrates. In this context, whorls formation may have pro-survival rather than pro-death function. It seems that whorls in different organisms and cell types exhibit only phenotypic convergence, with distinct biogenesis mechanisms having evolved independently and not being universally present across all cell types.</p>\u0000 </div>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 11","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Ibrokhim Sapaev, Ozodbek Nematov, Rustam Turakulov, Sapaev Bayramdurdi, Nafisa O Turaeva, Neeraj Bainsal, Pankaj Bansal, Aseel Smerat
{"title":"Mapping Osteosarcoma Biology With CRISPR/Cas: From Gene Function to Therapeutic Targets.","authors":"Amr Ali Mohamed Abdelgawwad El-Sehrawy, Ibrokhim Sapaev, Ozodbek Nematov, Rustam Turakulov, Sapaev Bayramdurdi, Nafisa O Turaeva, Neeraj Bainsal, Pankaj Bansal, Aseel Smerat","doi":"10.1002/cbin.70233","DOIUrl":"https://doi.org/10.1002/cbin.70233","url":null,"abstract":"<p><p>Osteosarcoma is a highly aggressive primary bone malignancy characterized by rapid proliferation, chemoresistance, and early metastasis. Recent advances in CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) genome editing have enabled precise targeting of oncogenes, tumor suppressors, and regulators of epigenetic, metabolic, and signaling pathways, providing new insights into osteosarcoma biology. CRISPR-mediated knockout of cell-cycle regulators, including CDK11, impairs proliferation, while restoration of TP53 and suppression of TERT promoter activity inhibits tumor growth. Other line of studies has revealed that chemoresistance mechanisms mediated by ABCB1/MDR1, CD44, ATR, RAD18, and autophagy-related genes have been effectively reversed through CRISPR interventions, restoring sensitivity to cisplatin and doxorubicin. Furthermore, CRISPR applications in immune modulation, such as PD-L1 knockout, may enhance antitumor immunity. Importantly, high-throughput CRISPR screens also may identify essential genes, novel oncogenic drivers, and synthetic lethal targets, thus informing potential precision therapeutic strategies. This review aims to critically summarize CRISPR/Cas-mediated studies in osteosarcoma, focusing on targeting oncogenes and tumor suppressors, overcoming chemoresistance, modulating immune responses, regulating metabolism and autophagy, and identifying essential genes and vulnerabilities, providing a translational framework for precision therapy.</p>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 11","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ali M Atoom, Omer Qutaiba B Allela, Priya Priyadarshini Nayak, Vimal Arora, Siya Singla, Zainab H Athab, Dilbar Urazbaeva, Rasul Usmanov
{"title":"Epigenome, Microbiome, and Metabolites: Unraveling the Complex Pathogenesis of Celiac Disease.","authors":"Ali M Atoom, Omer Qutaiba B Allela, Priya Priyadarshini Nayak, Vimal Arora, Siya Singla, Zainab H Athab, Dilbar Urazbaeva, Rasul Usmanov","doi":"10.1002/cbin.70231","DOIUrl":"https://doi.org/10.1002/cbin.70231","url":null,"abstract":"<p><p>Celiac disease (CeD) is a chronic autoimmune disease triggered by gluten consumption in genetically susceptible individuals, primarily those with HLA-DQ2 or HLA-DQ8 haplotypes. Although these genetic factors are responsible for a substantial portion of disease risk, they do not fully explain disease heritability or the rising incidence observed worldwide. Recent clinical studies highlight epigenetic modifications-including DNA methylation, histone modifications, non-coding RNA regulation, and RNA methylation-as critical mediators bridging genetic susceptibility and environmental influences, such as gut microbiota dysbiosis, dietary patterns, early-life exposures, infections, and pharmaceutical interventions. These epigenetic mechanisms modulate immune responses, intestinal barrier function, and inflammatory pathways, contributing to the loss of gluten tolerance and perpetuation of mucosal damage. Key players, including tissue transglutaminase 2 (TG2) and interferon-gamma (IFN-γ), form amplifying feedback loops that exacerbate pathogenesis. Bacterial metabolites and lifestyle factors further influence epigenetic landscapes, offering reversible targets for intervention. This review synthesizes current evidence on epigenetic alterations in CeD, emphasizing their interplay with microbiota and metabolites, tissue-specific patterns, and potential as biomarkers. It also explores implications for novel therapeutic strategies beyond the gluten-free diet, including epigenetic modulators and microbiota-targeted approaches, to advance personalized prevention and management of CeD.</p>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 11","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Putri Cahaya Situmorang, Cheryl Grace Pratiwi Rumahorbo, Rony Abdi Syahputra, Etti Sartina Siregar, Alberico Catapano
{"title":"PCSK9 as a Regulatory Network: Molecular Mechanisms, Therapeutic Targeting, and Herbal Modulation.","authors":"Putri Cahaya Situmorang, Cheryl Grace Pratiwi Rumahorbo, Rony Abdi Syahputra, Etti Sartina Siregar, Alberico Catapano","doi":"10.1002/cbin.70232","DOIUrl":"https://doi.org/10.1002/cbin.70232","url":null,"abstract":"<p><p>Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a central regulator of cholesterol homeostasis through its role in promoting low-density lipoprotein receptor (LDLR) degradation and limiting hepatic low-density lipoprotein cholesterol (LDL-C) clearance. The clinical success of monoclonal antibodies and small interfering RNA (siRNA)-based therapies has established PCSK9 as an important therapeutic target. However, PCSK9 biology extends beyond its canonical role in LDLR degradation, with its expression and activity regulated through interconnected transcriptional, post-transcriptional, metabolic, and intracellular signaling mechanisms involving sterol regulatory element-binding protein-2 (SREBP-2), hepatocyte nuclear factor-1α (HNF-1α), microRNAs, and multiple signaling pathways. This regulatory complexity is illustrated by compensatory responses, including statin-induced PCSK9 expression, and by observations that changes in PCSK9 expression do not always directly predict overall metabolic outcomes. Current therapeutic strategies primarily target circulating PCSK9 or suppress its hepatic synthesis, whereas upstream and multi-level regulatory mechanisms remain less extensively explored. Herbal-derived compounds have emerged as potential multi-target modulators of the PCSK9 regulatory network, with experimental studies indicating that phytochemicals and plant extracts may influence PCSK9 through coordinated effects on transcriptional regulators, cellular signaling pathways, and LDLR expression. Nevertheless, the available evidence is heterogeneous, with substantial variation in experimental models, phytochemical composition, dosing strategies, and mechanistic endpoints. This review integrates current evidence on the molecular regulation of PCSK9, established and emerging therapeutic strategies, and herbal modulation across in vitro, in vivo, and in silico studies. Overall, the evidence supports a network-based interpretation of PCSK9 regulation and suggests that multi-target herbal modulation may provide a complementary strategy to conventional PCSK9-directed therapies by acting at multiple regulatory levels. However, the predominantly preclinical nature of the available evidence underscores the need for standardized phytochemical characterization, rigorous mechanistic validation, and well-designed clinical studies before therapeutic translation can be established.</p>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 11","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"HSPD1 Regulates C2C12 Cell Proliferation and Differentiation in Association With Mitochondrial Function Changes","authors":"Yuhui Wang, Kai Liu, Haijing Luo, Wentian Zhang, Xingjun Xu, Qingzhu Yang, Weiwei Zhang","doi":"10.1002/cbin.70228","DOIUrl":"10.1002/cbin.70228","url":null,"abstract":"<div>\u0000 \u0000 <p>HSPD1 is an important chaperone protein whose primary function is to assist the correct folding of mitochondrial proteins and its co-chaperone. It exerts multiple biological effects, including participation in protein homeostasis maintenance, stress resistance, and cellular protection. However, whether <i>Hspd1</i> modulates the proliferation and differentiation of C2C12 cells remains unclear. In this study, we observed that overexpression or knockdown of the <i>Hspd1</i> gene increased or decreased C2C12 cell proliferation, respectively, whereas differentiation exhibited the opposite trend. Furthermore, co-immunoprecipitation coupled with mass spectrometry identified several putative HSPD1-interacting partners. Functional assays revealed that altering <i>Hspd1</i> expression correlated with changes in the expression of mitochondrial morphology-related genes, transcripts of components of the tricarboxylic acid cycle and electron transport chain, as well as intracellular ATP levels. Although these results are consistent with the hypothesis that HSPD1-associated mitochondrial alterations may contribute to myoblast behavior, they do not exclude other potential mechanisms. Collectively, this study provides correlative evidence linking <i>Hspd1</i> to mitochondrial regulation in C2C12 cells and underscores the necessity for further mechanistic dissection, including rescue experiments to establish causality.</p></div>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 11","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149219998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"B Cell Deficiency Protects Against the Development of c-MET and Beta-Catenin Driven Hepatocellular Carcinoma in Mice","authors":"Fang Wang, Eun Bi Lim, Rehan Mehta, Yee Ling Wu","doi":"10.1002/cbin.70227","DOIUrl":"https://doi.org/10.1002/cbin.70227","url":null,"abstract":"<p>Hepatocellular carcinoma (HCC), a lethal form of liver cancer, continues to show rising mortality rates despite advancements in immunotherapies. This highlights the need for more effective treatments. Recent studies linked the presence of B cells within human tumors, including HCC, to improved responses to immunotherapy and better prognoses. Specifically, tumor-infiltrating B cells have been associated with reduced cancer cell proliferation, suggesting that B cell-mediated responses may be harnessed as a potential therapeutic strategy against HCC. However, in advanced HCC, IL-10-producing regulatory B cells accumulate and promote tumor growth. These paradoxical findings on B cells in human HCC highlight the necessity for clarifying the specific functions of B cells in HCC development to develop B cell-targeted therapies. To investigate the role of B cells in HCC, we used B cell-deficient (muMT) mice and anti-CD20 antibodies to deplete B cells in WT mice. In both systems, we observed a strong protection against liver tumor formation upon HCC induction, indicating the presence of a potent anti-tumor effect in the absence of B cells before HCC induction. Additionally, depletion of B cells after tumor foci have formed in the liver at later stage of HCC also potently suppressed tumor growth. Functionally, depletion of CD4<sup>+</sup> and CD8<sup>+</sup> T cells partially restored susceptibility to tumor growth, suggesting that B cell depletion suppresses HCC development partly through enhanced T cell-mediated immunity. These findings reveal an underappreciated tumor-suppressing effect of B cells in HCC and suggest that targeting the mechanisms of B cell suppression may boost anti-tumor responses in HCC.</p>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 11","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cbin.70227","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"SIRT6 Inhibits Glycolysis and Cementogenesis via Targeting IRS2","authors":"Liyuan Huang, Jie Shen, Zhebin Cheng, Jian Yuan, Peng Deng, Lijie Fan, Qianming Chen","doi":"10.1002/cbin.70226","DOIUrl":"10.1002/cbin.70226","url":null,"abstract":"<div>\u0000 \u0000 <p>Cementum shares similar characteristics with bone in terms of biochemical composition. Recent studies have reported that glycolysis is the main energy source driving osteoblast differentiation, but the role of glycolysis in cementoblast differentiation remains elusive. Previously, we found Sirtuin 6 (SIRT6) suppressed cementoblast differentiation and mineralization via inhibiting glucose transporter 1 (GLUT1), indicating that glycolysis may also be required for cementogenesis. However, the underlying mechanisms remain largely unknown. In this study, we observed that the expression of glycolytic enzymes increased progressively during cementoblast differentiation. Measurements of extracellular acidification rate, glucose uptake, lactate release, and gain-and-loss of function demonstrated that overexpressing SIRT6 in immortalized mouse cementoblasts (OCCM-30) suppressed cementoblast glycolysis. Mechanistically, chromatin immunoprecipitation assay results revealed that SIRT6 inhibits insulin receptor substrate 2 (IRS2) transcription by deacetylating histone H3 at lysine K9 (H3K9). Overexpression of IRS2 promoted OCCM-30 glycolysis and mineralization through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway, whereas SIRT6 significantly inhibited PI3K/AKT pathway activity. Overall, our results demonstrate that SIRT6 inhibits IRS2 transcription by deacetylating histone H3K9, thereby reducing PI3K/AKT signaling-induced glycolysis and suppressing cementoblast mineralization.</p></div>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 10","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149191623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bromodomain-Containing Protein 4 in Ischemia-Reperfusion Injury: Mechanisms, Preclinical Evidence, and Translational Challenges","authors":"Namrata Vadak, Lokesh Kumar Bhatt","doi":"10.1002/cbin.70223","DOIUrl":"10.1002/cbin.70223","url":null,"abstract":"<div>\u0000 \u0000 <p>Ischemia reperfusion (IR) injury is a major contributor to tissue damage and organ dysfunction following ischemic events and clinical interventions such as thrombolysis, revascularization, and transplantation, yet effective pharmacological strategies to limit this injury remain limited. Bromodomain-containing protein 4 (BRD4), an epigenetic reader that recognizes acetylated lysine residues to drive super-enhancer-associated transcription. Upregulated BRD4 has emerged as a key regulator of the inflammatory, endothelial, and cell death pathways underlying post-IR injury pathophysiology. Preclinical evidence across cerebral, cardiac, renal, and hepatic IR injury models indicates that BRD4 hyperactivation amplifies NFκB-dependent inflammatory signaling, while its pharmacological or genetic inhibition confers substantial tissue protection. This review synthesizes current mechanistic understanding of BRD4 in IR injury pathogenesis, evaluates emerging BET/BRD4-targeted therapeutic strategies, and outlines key translational challenges for advancing epigenetic pharmacology toward clinical application in IR-associated disorders.</p>\u0000 </div>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 10","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Quan Liu, Tao Luo, Jiachao Xiong, Xiaohua Jiang, Tonghua Zhou, Shiding Jiang, Gangan Liu, Xia Lan
{"title":"circCDR1as/miR-671-5p Axis Modulates Chondrocyte Ferroptosis and Macrophage Reprogramming via Targeting NCOA4 and TLR4 in Legg-Calvé-Perthes Disease","authors":"Quan Liu, Tao Luo, Jiachao Xiong, Xiaohua Jiang, Tonghua Zhou, Shiding Jiang, Gangan Liu, Xia Lan","doi":"10.1002/cbin.70207","DOIUrl":"10.1002/cbin.70207","url":null,"abstract":"<div>\u0000 \u0000 <p>Legg-Calvé-Perthes disease (LCPD) causes malformations of femoral head in children, which presents as a treatment challenge due to its unclear pathogenesis. This study aimed to investigate the influence of circCDR1as on LCPD and its related mechanisms. An in vivo LCPD model was established in spontaneously hypertensive rats (SHRs) and HMGB1-stimulated chondrocytes were used to mimic LCPD in vitro. We found that circCDR1as was up-regulated, while miR-671-5p was down-regulated in LCPD patients, which exhibited a negative correlation. Depletion of circCDR1as restored the proliferation and inhibited -ferroptosis of HMGB1-exposed chondrocytes, Mechanistically, circCDR1as silencing increased miR-671-5p expression that targeted NCOA4 mRNA to disrupt the NCOA4-FTH1 interaction-mediated ferritinophagy. Moreover, treatment with conditioned medium (CM) of circCDR1as-silenced chondrocytes repressed M1 macrophage polarization via enhancing miR-671-5p expression that subsequently targeted TLR4 mRNA to inactivate TLR4/NF-κB pathway. FUS was responsible for circCDR1as biogenesis via the direct binding to pre-CDR1as mRNA. Collectively, chondrocyte ferroptosis was triggered by FUS-activated circCDR1as via sponging miR-671-5p to enhance NCOA4-FTH1 interaction-mediated ferritinophagy, which resulted in M1 macrophage reprogramming via activating the TLR4/NF-κB pathway, thus promoting LCPD development.</p></div>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 10","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marissa K. Caldow, Kristy Swiderski, John H. V. Nguyen, Emily S. Haber, Kyla J. H. Fritz, Gordon S. Lynch
{"title":"Tomatidine Exposure During Early Myogenesis Promotes Hypertrophy of C2C12 Muscle Cells Through Increased Nuclei Accretion","authors":"Marissa K. Caldow, Kristy Swiderski, John H. V. Nguyen, Emily S. Haber, Kyla J. H. Fritz, Gordon S. Lynch","doi":"10.1002/cbin.70224","DOIUrl":"10.1002/cbin.70224","url":null,"abstract":"<p>During myogenesis or myofiber regeneration, a proliferating muscle cell must leave the cell cycle, commit to differentiate, and fuse to neighboring myoblasts to create multinucleated myotubes, and eventually mature myofibers. These stages can be manipulated by exogenous factors including signaling molecules, mechanical cues, and nutrient supplementation. Supplementation with bioactives, such as tomatidine, can improve aspects of skeletal muscle health when evaluated using in vitro and in vivo models. In this study, a phenotypic characterization of the effects of tomatidine supplementation during proliferation, early maturation and differentiation, was undertaken in C2C12 muscle cells, cultured in growth medium, or alternatively induced to differentiate in medium supplemented with 10 µM tomatidine, for up to 4 days. Real-time impedance assays indicated tomatidine slowed C2C12 proliferation after 3 days of supplementation. Tomatidine supplementation from the onset of differentiation induced myotube hypertrophy within the first 48 h of maturation. Tomatidine-induced hypertrophy was driven by increased myonuclei fusion in developing myotubes with a concomitant increase in protein synthesis. Taken together, tomatidine's growth promoting effects on skeletal muscle cells identify its therapeutic potential for enhancing muscle regeneration and repair, by mechanisms that improve myofiber maturation and function.</p>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 10","pages":""},"PeriodicalIF":3.5,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cbin.70224","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149135043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}